imgHeader.jpg

Innovation in Regenerative Technologies

There are a number of new and exciting technologies emerging for the treatment of periodontal regeneration and dental implantology. Recombinant platelet derived growth factor (Rh-PDGF) is a new technology that is gaining attention for the possibilities it offers.

In order to best serve Healthcare Professionals in the future, we would value your opinions and an overview of your current practice. We would appreciate your help by completing this survey.

The survey is divided into two research sections relating to periodontal disease and dental implantology. Please complete the relevant sections relating to your practice.

All information received will be treated as strictly confidential and will not be passed to any 3rd parties.

Thank you for your assistance

Part I: Periodontal Regeneration

1. Do you carry out surgical periodontal regenerative procedures?

Yes:   No:

2. Approximately how many of these procedures do you carry out each month?

QuantityPlease Tick
Less than 1
1 - 5
5 - 10
10 - 20
> 20

3. Do you use any of the following for periodontal regeneration?

ProceduresNo./monthImportance *
GTR / Barrier membranes
Emdogain™
BioOss™
Autologous bone grafts
Easy-Graft™
Others - Please state

* Rank in order, 1 - least important to 6 - most important

4. What type of indications do you use these materials for?

IndicationsPlease Tick
Single 2/3 wall infrabony pocket
Single 1 wall infrabony pocket
Multiple infrabony pockets
Class II furcation lesions
Class III furcation lesions
Mucogingival/root coverage procedures
Others - Please state

5. What are the most important limitations of current materials and procedures?

LimitationImportance*
Predictability of outcome
Magnitude of outcome (amount of attachment, bone fill)
Speed of healing
Technical difficulty of procedure
Cost to patient

* Rank in order, 1 - least important to 5 - most important

6. Are there other major limitations not mentioned in question 5 ?

7. Which of these attributes would you consider to be important for a new regenerative material compared to existing materials?

AttributesImportance *
More predictable
Faster rate of healing
Faster rate of linear bone height growth
Greater linear bone height gain
Greater gain in CAL
Cost to patient

* Rank in order, 1 - least important to 6 - most important

8. Are you aware of any of the following?

ProductsPlease Tick
Bone Morphogenic Protein (BMP)
Rh-Platelet Derived Growth Factor (Rh-PDGF)

9. Do you think you are likely to use "new" regenerative products for periodontal procedures in the future?

Yes:   No:

10. What clinical outcomes would you like to achieve with an innovative product for periodontal regeneration?

11. Your clinical practice

Please Tick
General Practice
Specialist Practice
Hospital / University Practice
Community Based Practice

12. Do you have a postgraduate clinical qualification?

Please Tick
MSc.
MClin Dent.
Other - Please State:

13. Is your practice restricted to Periodontology?

Yes:   No:

If No please specify:

Part II: Bone Regeneration in Implant Dentistry

1. Do you carry out surgical procedures for placement of dental implants?

Yes:   No:

2. Approximately how many of these procedures do you carry out each month?

QuantityPlease Tick
Less than 1
1 - 5
5 - 10
10 - 20
> 20

3. Do you use any of the following for managing bone regeneration?

ProceduresNo./monthImportance *
GTR / Barrier membranes
Emdogain™
BioOss™
Autologous bone grafts
Easy-Graft™
Others - Please state

* Rank in order, 1 - least important to 6 - most important

4. What type of indications do you use these materials for?

IndicationsPlease Tick
Sinus lifts
Extraction sockets
Ridge augmentation
Immediate Implant placements
Minor bony defects in ridges during placements
Others - Please state

5. What do you find are the most important limitations of current materials and procedures?

LimitationImportance*
Predictability of outcome
Magnitude of outcome (amount of attachment, bone fill)
Speed of healing
Technical difficulty of procedure
Cost to patient
Morbidity to patient (autografts)

* Rank in order, 1 - least important to 6 - most important

6. Are there other major limitations not mentioned above?

7. Which of these attributes would you consider to be important for a new regenerative material compared to existing materials?

AttributesImportance*
More predictable
Faster rate of healing
Faster rate of linear bone height growth
Less patient morbidity
Easier to use
Cost

8. Are you aware of any of the following?

ProductsPlease Tick
Bone Morphogenic Protein (BMP)
Rh-Platelet Derived Growth Factor (Rh-PDGF)

9. Do you think you are likely to use "new" regenerative products for implant procedures in the future?

Yes:   No:

10. What clinical outcomes would you like to achieve with an innovative product for bone regeneration?

11. Your clinical practice

Please Tick
General Practice
Specialist Practice
Hospital / University Practice
Community Based Practice

12. Do you have a postgraduate clinical qualification?

Please Tick
MSc.
MClin Dent.
Other - Please State:

13. Is your practice restricted to implantology?

Yes:   No:
Syner-Med provides details of each product specific to Healthcare Professionals or patients and families.
Please choose which kind of information you need by selecting one of these buttons.